Algenis is an known in the R&D of natural sodium channel blocker molecules derived from microalgae. The company aims to be a leader in the production, formulation, and clinical development of bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. Algenis' strategy is to commercialize our products through licensing, co-development, or direct sales options. Algenis' first therapeutic indication is for the treatment and healing of anal fissures.
| Website | http://www.algenis.com |
| Revenue | $405000 |
| Employees | View employees |
| Founded | 2002 |
| Address | 1500 Ñuñoa, Santiago, Santiago Metropolitan, CL |
| Phone | +56 9 4241 0127 |
| Industry | Biotechnology, Business Services General, Business Services, Science and Engineering, Laboratory Services (Healthcare), Innovation Management, Pharmaceutical, Health Care, Product Research, Data and Analytics, Design |
| Competitors | BASF, DuPont, Evonik, FMC Corporation, Corbion, Nutraceutical Products Co, Zymergen, Inc., Solazyme , Inc., Phytonix Corporation, Algae Systems, LLC +22 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Algenis employee's phone or email?
Algenis Questions
The Algenis annual revenue was $405000 in 2026.
Algenis is based in Santiago, Santiago Metropolitan.
The NAICS codes for Algenis are [541713, 541, 5417, 54, 54171].
The SIC codes for Algenis are [87, 873].
